β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation

NCT01944033 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Acute Exacerbation of Chronic Obstructive Airways Disease

Interventions

DRUG: Bricanyl/Iprovent
DRUG: Bricanyl

Sponsor

University of Monastir